Ionis Pharmaceuticals
Trade Ionis Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
Ionis Pharmaceuticals(IONS) stock is priced at $56.18, giving the company a market capitalization of 9.51B. It carries a P/E multiple of -16.48.
As of 2026-08-15, Ionis Pharmaceuticals(IONS) stock has fluctuated between $55.16 and $57.24. The current price stands at $56.18, placing the stock +1.8% above today's low and -1.9% off the high.
Ionis Pharmaceuticals(IONS) shares are trading with a volume of 1.35M, against a daily average of 2.2M.
In the last year, Ionis Pharmaceuticals(IONS) shares hit a 52-week high of $86.74 and a 52-week low of $41.71.
In the last year, Ionis Pharmaceuticals(IONS) shares hit a 52-week high of $86.74 and a 52-week low of $41.71.
IONS News
...
Ionis Pharmaceuticals Inc. ((IONS)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing...
Ionis Pharmaceuticals recently secured FDA approval for TRYNGOLZA, the first medicine to lower triglycerides and reduce acute pancreatitis risk in adults with s...
Analyst ratings
85%
of 26 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.